Hidradenitis suppurativa and the metabolic syndrome

Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients

(2015) G. Shalom et al.   BRITISH JOURNAL OF DERMATOLOGY

Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities

(2014) J.J. Crowley et al.   BRITISH JOURNAL OF DERMATOLOGY

The prevalence of metabolic syndrome in patients with hidradenitis suppurativa

(2014) Daniel A. Gold et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: A chart-verified case-control analysis

(2014) Julia Shlyankevich et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Association of Metabolic Syndrome and Hidradenitis Suppurativa

(2014) Iben Marie Miller et al.   JAMA Dermatology

Hidradenitis suppurrativa (acne inversa) as a systemic disease

(2013) Clio Dessinioti et al.   CLINICS IN DERMATOLOGY

Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States

(2013) Irene Cosmatos et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Increased Prevalence of Metabolic Syndrome in Patients with Acne Inversa

(2012) Robert Sabat et al.   PLoS One

Metabolic syndrome: definitions and controversies

(2011) Eva Kassi et al.   BMC Medicine

Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial

(2010) Annika Grant et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies

(2008) Jean E. Revuz et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY